Rare diseases
Investigational molecules
Locations
Back to Poland902 clinical trials in Bydgoszcz, Poland across 6 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study on Rosnilimab for Patients with Moderate to Severe Rheumatoid Arthritis
PolandLong-term Study of Zanubrutinib for Patients with B-cell Blood Cancer
PolandStudy of Datopotamab Deruxtecan and Durvalumab for Adults with Untreated Triple-Negative or Hormone Receptor-Low/HER2-Negative Breast Cancer
PolandStudy on the Safety of Tafasitamab and Lenalidomide for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
PolandStudy Comparing Acalabrutinib and Venetoclax with Venetoclax and Obinutuzumab for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
PolandStudy on the Safety and Immune Response of V116 Vaccine in Children and Adolescents at Higher Risk for Pneumococcal Disease
PolandStudy of AZD5305 with Abiraterone Acetate and Darolutamide in Men with Metastatic Castration-Sensitive Prostate Cancer
PolandStudy on the Safety and Effectiveness of Upadacitinib for Adults and Adolescents with Severe Alopecia Areata
PolandStudy of V940 and Pembrolizumab for Patients with Renal Cell Carcinoma After Surgery
PolandStudy on the Effectiveness and Safety of Obinutuzumab for Patients with Systemic Lupus Erythematosus
PolandStudy of Belzutifan with Lenvatinib versus Cabozantinib in Adults with Advanced Renal Cell Carcinoma Who Have Previously Received Anti-PD-1/L1 Treatment
PolandStudy on Budigalimab and ABBV-382 for People with HIV on Stable Antiretroviral Therapy
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on respiratory syncytial virus (RSV) and pneumococcal infections in both adults and children. Studies include vaccine development for multiple age groups and assessment of immune responses.
Research emphasizes preventive measures and vaccine efficacy across different age groups.
Groundbreaking research into neurodegenerative conditions, with particular focus on early intervention strategies for Alzheimer's and Parkinson's disease treatment approaches.
Studies aim to slow disease progression and improve patient outcomes.
Comprehensive trials examining new treatments for various inflammatory disorders, including psoriasis, arthritis, and inflammatory bowel diseases.
Focus on developing targeted therapies for chronic inflammatory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
